Biogen Cuts 11 % of Its Workforce Amid MS Drug Sales Slowdown
The world's biggest drug company has announced plans to cut hundreds of jobs and reduce operating expenses in a bid to tackle the growing threat of multiple sclerosis drugs in the US and beyond, according to analysts.
Source: bnnbloomberg.caPublished on 2023-07-25
Related news
- Building a 5 - star FM - PM Concierge Service
- DWS CEO Will Tone Down Hyped - UP ESG Sales Pitches Amid Greenwashing Scandal
- Fund Manager Snubs ESG Stock Favorites and Handily Beats Peers
- Green bonds are set to drive corporate ESG debt out of slump in 2023 - Barclays | Hellenic Shipping News Worldwide
- Deutsche Bank raided in greenwashing probe
- Pressure mounting on $318b energy giant that says it cares about climate
- Abrdn to slash Australian workforce but remains committed to the market
- Billionaires promote CO2 - removing schemes to protect climate
- Billionaires promote CO2 - removing schemes to protect climate
- Nuveen mulls buying Galapagos bond , impact metrics are key
- Why Air NZ sleep pods are hot in a bad way
- Gun policy debate moves to the ballot box
- Deutsche Bank , DWS raided over allegations of greenwashing
- FTSE 100 Closes Down 1 . 1 % as Early Year Optimism Runs Into Turbulence
- Greenpeace accused of greenwashing Egypt image ahead of Cop27 | Cop27